Study of Safety and Efficacy of RVL-1201 in the Treatment of Blepharoptosis

NCT03565887 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

164

Enrollment

INDUSTRY

Sponsor class

Conditions

Blepharoptosis

Interventions

DRUG: RVL-1201
OTHER: Vehicle ophthalmic solution

Sponsor

RVL Pharmaceuticals, Inc.